Cloning of partial cDNAs for the chicken glucocorticoid and mineralocorticoid receptors and characterization of mRNA levels in the anterior pituitary gland during chick embryonic development

2007 ◽  
Vol 33 (2) ◽  
pp. 226-239 ◽  
Author(s):  
Tom E. Porter ◽  
Sarvin Ghavam ◽  
Michael Muchow ◽  
Ioannis Bossis ◽  
Laura Ellestad
Endocrinology ◽  
1989 ◽  
Vol 125 (4) ◽  
pp. 2221-2223 ◽  
Author(s):  
THOMAS P. SEGERSON ◽  
KAREN S.L. LAM ◽  
LUCINDA CACICEDO ◽  
NAOTO MINAMITANI ◽  
J. STEPHEN FINK ◽  
...  

1988 ◽  
Vol 412 (4) ◽  
pp. 323-327 ◽  
Author(s):  
Takatoshi Tashima ◽  
Tetsuyuki Kitamoto ◽  
Jun Tateishi ◽  
Koji Ogomori ◽  
Hiroyuki Nakagaki

Life Sciences ◽  
2003 ◽  
Vol 73 (19) ◽  
pp. 2421-2432 ◽  
Author(s):  
Daniel Pisera ◽  
Marianela Candolfi ◽  
Andrea De Laurentiis ◽  
Adriana Seilicovich

1990 ◽  
Vol 124 (2) ◽  
pp. 327-NP ◽  
Author(s):  
T. H. Jones ◽  
C. D. Figueroa ◽  
C. Smith ◽  
D. R. Cullen ◽  
K. D. Bhoola

ABSTRACT Immunoreactive tissue kallikrein was co-localized with prolactin in all the eleven prolactin-secreting adenomas of the human anterior pituitary gland examined in this study. The intracellular distribution of immunoreactivity in the prolactin-secreting cells suggests that tissue kallikrein is located within the Golgi complex of these cells. Both the intracellular hormone-processing action and the kininogenase activity of tissue kallikrein may be of functional importance in human prolactinomas. Journal of Endocrinology (1990) 124, 327–331


1988 ◽  
Vol 47 (2) ◽  
pp. 142-148 ◽  
Author(s):  
Wayne B. Watkins ◽  
Lloyd G. Moore ◽  
Joachim Spiess

Endocrinology ◽  
2013 ◽  
Vol 154 (1) ◽  
pp. 308-319 ◽  
Author(s):  
Laura E. Ellestad ◽  
Tom E. Porter

Glucocorticoids play a role in functional differentiation of pituitary somatotrophs and lactotrophs during embryogenesis. Ras-dva was identified as a gene regulated by anterior neural fold protein-1/homeobox expressed in embryonic stem cells-1, a transcription factor known to be critical in pituitary development, and has an expression profile in the chicken embryonic pituitary gland that is consistent with in vivo regulation by glucocorticoids. The objective of this study was to characterize expression and regulation of ras-dva mRNA in the developing chicken anterior pituitary. Pituitary ras-dva mRNA levels increased during embryogenesis to a maximum on embryonic day (e) 18 and then decreased and remained low or undetectable after hatch. Ras-dva expression was highly enriched in the pituitary gland on e18 relative to other tissues examined. Glucocorticoid treatment of pituitary cells from mid- and late-stage embryos rapidly increased ras-dva mRNA, suggesting it may be a direct transcriptional target of glucocorticoids. A reporter construct driven by 4 kb of the chicken ras-dva 5′-flanking region, containing six putative pituitary-specific transcription factor-1 (Pit-1) binding sites and two potential glucocorticoid receptor (GR) binding sites, was highly activated in embryonic pituitary cells and up-regulated by corticosterone. Mutagenesis of the most proximal Pit-1 site decreased promoter activity in chicken e11 pituitary cells, indicating regulation of ras-dva by Pit-1. However, mutating putative GR binding sites did not substantially reduce induction of ras-dva promoter activity by corticosterone, suggesting additional DNA elements within the 5′-flanking region are responsible for glucocorticoid regulation. We have identified ras-dva as a glucocorticoid-regulated gene that is likely expressed in cells of the Pit-1 lineage within the developing anterior pituitary gland.


1990 ◽  
Vol 127 (3) ◽  
pp. 437-NP ◽  
Author(s):  
P. M. Jones ◽  
D. J. O'Halloran ◽  
M. A. Ghatei ◽  
J. Domin ◽  
S. R. Bloom

ABSTRACT Neuropeptide Y (NPY), neurotensin (NT), substance P (SP) and vasoactive intestinal peptide (VIP) are four structurally unrelated neuroendocrine peptides which affect anterior pituitary function. All four peptides appear to be locally synthesized in the anterior pituitary gland and have been shown to be regulated by thyroid and/or sex hormone status. We show here that NT, SP and VIP but not NPY are influenced by adrenal hormone status in the male rat pituitary gland. Adrenalectomy increased the content of VIP (35·4±4·0 (s.e.m.) vs control 11·9±1·1 pmol/g wet weight) but decreased that of SP (18·8±2·3 vs control 36·7 ±3·9 pmol/g wet weight). Adrenalectomy combined with castration decreased the content of SP (14·6±3·5 vs control 36·7±3·9 pmol/g wet weight) but had no effect on VIP content. Treatment with dexamethasone produced significant decreases in NT, SP and VIP contents (17·8±2·3 vs control 32·6±3·4 pmol/g wet weight, 5·5±0·9 vs control 36·7±3·9 pmol/g wet weight and 4·2±0·6 vs control 11·9±1·1 pmol/g wet weight respectively). The changes in pituitary peptide contents occurred in parallel with changes in mRNA levels, suggesting that alterations in glucocorticoid hormone status can alter the synthesis of these peptides. These results, together with the known effects of these neuroendocrine peptides suggest possible functions for locally produced SP and VIP in regulating the secretion of adrenocorticotrophin and/or other proopiomelanocortin-derived peptides. The differential effects of adrenalectomy and adrenalectomy combined with castration on VIP suggests that the regulation of this pituitary peptide is complex, and may be dependent, in part at least, on gonadal factors. Journal of Endocrinology (1990) 127, 437–444


Sign in / Sign up

Export Citation Format

Share Document